CRISPR upped to outperform by Evercore on upcoming data
Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
Wells Fargo initiates DENTSPLY with Equal Weight, $20 target
Wells Fargo (NYSE:WFC) began coverage on DENTSPLY SIRONA (NASDAQ: NASDAQ:XRAY) shares, assigning an Equal Weight rating and setting a price target of $20.00. The new rating comes as DENTSPLY SIRONA's ...
Evercore ISI Issues Positive Forecast for Confluent (NASDAQ:CFLT) Stock Price
Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...
Genuine Parts Company (GPC) Gets a Hold from Evercore ISI
In a report released yesterday, Greg Melich from Evercore ISI maintained a Hold rating on Genuine Parts Company (GPC – Research Report), with a ...
Evercore ISI Remains a Buy on Ascendis Pharma (ASND)
In a report released yesterday, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on Ascendis Pharma (ASND – Research Report), with ...
Walgreens, VillageMD Tap Advisers as Liabilities Mount
Walgreens Boots Alliance Inc. is getting advice from Perella Weinberg Partners and AlixPartners for help with its operations ...
Fintel on MSN23h
Evercore ISI Group Downgrades Trade Desk (TTD)
Fintel reports that on February 13, 2025, Evercore ISI Group downgraded their outlook for Trade Desk (NasdaqGM:TTD) from ...